Merck Consolidated Income Statement 

Sales

[1]

9,905.9

8,928.9

Royalty, license and commission income

[2]

370.5

361.7

Total revenues

10,276.4

9,290.6

Cost of sales

[3]

–2,788.3

–2,385.4

Gross margin

7,488.1

6,905.2

Marketing and selling expenses

[4]

–2,393.0

–2,234.5

Royalty, license and commission expenses

[5]

–500.5

–477.0

Administration expenses

[6]

–504.8

–478.2

Other operating expenses and income

[7]

–581.9

–390.4

Research and development

[8]

–1,517.1

–1,397.1

Amortization of intangible assets

[9]

–1,004.7

–818.6

Investment result

[10]

–1.0

4.1

Operating result

985.1

1,113.5

Exceptional items

[11]

151.8

–0.8

Earnings before interest and tax (EBIT)

1,136.9

1,112.7

Financial result

[12]

–285.8

–251.6

Profit before income tax

851.1

861.1

Income tax

[13]

–222.1

–219.6

Profit after tax

629.0

641.5

of which attributable to Merck KGaA shareholders

617.5

632.1

of which non-controlling interest

[14]

11.5

9.4

Earnings per share (in €)

[15]

basic

2.84

2.91

diluted

2.84

2.91